 DOWNLOAD CORPORATE FACT SHEET (PDF)  DOWNLOAD CORPORATE PRESENTATION (PDF) |
| Press Releases 2009 | |
|
December 8, 2009 |
|
 |
Cytheris Announces Initiation of CONVERT, a Phase I/IIa Study of Recombinant Human Interleukin-7 (CYT107) in Combination with Antiviral Therapy and Vaccination for Treatment of Chronic Hepatitis B Virus |
 |
|
|
November 23, 2009 |
|
|
Cytheris Announces Initiation of NCI/NIH-Sponsored Phase I/IIa Clinical Study of Tumor Vaccination and Interleukin-7 (IL-7) in Patients with High Risk Pediatric Solid Tumors |
|
|
|
October 14, 2009 |
|
|
Cytheris Announces Initiation of NIAID/NIH-Sponsored Phase I/IIa Clinical Trial of Interleukin-7 (IL-7) |
|
|
|
September 15, 2009 |
|
|
Cytheris Announces Interim Data From INSPIRE Study Showing Interleukin-7 (CYT107) Induces Dose-Dependent and Sustained Increase of CD4 T Cells in Chronic HIVInfected Patients |
|
|
|
September 9, 2009 |
|
|
Cytheris to Present Interim Data from INSPIRE HIV Multicenter Study in Oral Late Breaker at ICAAC |
|
|
|
July 8, 2009 |
|
|
Cytheris Announces Notice of Allowance for U.S. Patent Covering the Pharmaceutical Composition of its Recombinant Human Interleukin-7 (CYT107) |
|
|
|
May 26, 2009 |
|
|
Cytheris Announces Publication of Preclinical Study in Nature Medicine Showing Combination of Interleukin-7 with Viral Vaccine Boosts Immunity to Tumors |
|
|
|
May 12, 2009 |
|
|
Cytheris Announces Publication of IL-7 Primate Study Showing Rapid and Massive T cell Homing to the Gut |
|
|
March 17, 2009 |
|
|
Cytheris Announces Publication of IL-7 HIV Data |
|
|
